Protalix to propose virtual inspection to clear barrier to FDA approval

Protalix to propose virtual inspection to clear barrier to FDA approval

Source: 
Biopharma Reporter
snippet: 

Protalix BioTherapeutics is planning to propose a virtual or record review inspection to clear the barrier to approval of its Chiesi Farmaceutici-partnered Fabry disease treatment.